ReP USP - Resultado da busca

Artigo de periodico
Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting (2018)
Marinho, Rodolfo; Alcântara, Paulo Sérgio Martins de; Otoch, José Pinhata; Seelaender, Marília Cerqueira Leite
Source: Frontiers in Nutrition. Unidades: HU, FM, ICB
Subjects: MICRORNAS, CAQUEXIA, INFLAMAÇÃO, PERDA DE MASSA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARINHO, Rodolfo et al. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Frontiers in Nutrition, v. 4, n. ja 2018, p. 7 , 2018Tradução . . Disponível em: https://doi.org/10.3389/fnut.2017.00069. Acesso em: 07 nov. 2024.
APA
Marinho, R., Alcântara, P. S. M. de, Otoch, J. P., & Seelaender, M. C. L. (2018). Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Frontiers in Nutrition, 4( ja 2018), 7 . doi:10.3389/fnut.2017.00069
NLM
Marinho R, Alcântara PSM de, Otoch JP, Seelaender MCL. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting [Internet]. Frontiers in Nutrition. 2018 ; 4( ja 2018): 7 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fnut.2017.00069
Vancouver
Marinho R, Alcântara PSM de, Otoch JP, Seelaender MCL. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting [Internet]. Frontiers in Nutrition. 2018 ; 4( ja 2018): 7 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fnut.2017.00069
Artigo de periodico
Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth (2018)
Fort, Rafael Sebastián; Mathó, Cecilia; Geraldo, Murilo Vieira; Ottati, María Carolina; Yamashita, Alex Shimura; Saito, Kelly Cristina; Leite, Katia Ramos Moreira; Méndez, Manuel; Maedo, Noemí; Méndez, Laura; Garat, Beatriz; Kimura, Edna Teruko ; Silveira, José Roberto Sotelo; Duhagon, María Ana
Source: BMC Cancer. Unidades: ICB, FM
Subjects: METILAÇÃO DE DNA, NEOPLASIAS, NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORT, Rafael Sebastián et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, v. 18, n. 1, p. 13 , 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4049-7. Acesso em: 07 nov. 2024.
APA
Fort, R. S., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., Saito, K. C., et al. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18( 1), 13 . doi:10.1186/s12885-018-4049-7
NLM
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s12885-018-4049-7
Vancouver
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s12885-018-4049-7
Artigo de periodico
Metastasis of circulating tumor cells: speed matters (2018)
Freitas, Vanessa Morais ; Hilfenhaus, Georg; Arispe, Maria Luisa Iruela
Source: Developmental Cell. Unidade: ICB
Subjects: FLUXO SANGUÍNEO, CÉLULAS CULTIVADAS DE TUMOR, METÁSTASE NEOPLÁSICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Vanessa Morais e HILFENHAUS, Georg e ARISPE, Maria Luisa Iruela. Metastasis of circulating tumor cells: speed matters. Developmental Cell, v. 45, n. 1, p. 3-5, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.devcel.2018.03.005. Acesso em: 07 nov. 2024.
APA
Freitas, V. M., Hilfenhaus, G., & Arispe, M. L. I. (2018). Metastasis of circulating tumor cells: speed matters. Developmental Cell, 45( 1), 3-5. doi:10.1016/j.devcel.2018.03.005
NLM
Freitas VM, Hilfenhaus G, Arispe MLI. Metastasis of circulating tumor cells: speed matters [Internet]. Developmental Cell. 2018 ; 45( 1): 3-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.devcel.2018.03.005
Vancouver
Freitas VM, Hilfenhaus G, Arispe MLI. Metastasis of circulating tumor cells: speed matters [Internet]. Developmental Cell. 2018 ; 45( 1): 3-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.devcel.2018.03.005
Artigo de periodico
Eicosanoid and cancer (2018)
Gomes, Renata Nascimento ; Souza, Felipe da Costa ; Colquhoun, Alison
Source: Clinics. Unidade: ICB
Subjects: EICOSANOIDES, NEOPLASIAS, PROSTAGLANDINAS, INFLAMAÇÃO, LIPOXIGENASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Renata Nascimento e SOUZA, Felipe da Costa e COLQUHOUN, Alison. Eicosanoid and cancer. Clinics, v. 73, p. 1-10, 2018Tradução . . Disponível em: https://doi.org/10.6061/clinics/2018/e530s. Acesso em: 07 nov. 2024.
APA
Gomes, R. N., Souza, F. da C., & Colquhoun, A. (2018). Eicosanoid and cancer. Clinics, 73, 1-10. doi:10.6061/clinics/2018/e530s
NLM
Gomes RN, Souza F da C, Colquhoun A. Eicosanoid and cancer [Internet]. Clinics. 2018 ; 73 1-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.6061/clinics/2018/e530s
Vancouver
Gomes RN, Souza F da C, Colquhoun A. Eicosanoid and cancer [Internet]. Clinics. 2018 ; 73 1-10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.6061/clinics/2018/e530s
Artigo de periodico-carta/editorial
Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy (2017)
Chammas, Roger; Andrade, Luciana Nogueira de Sousa; Jancar, Sonia
Source: Nature reviews cancer. Unidades: FM, ICB
Subjects: APOPTOSE, NEOPLASIAS, ONCOGENES, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAMMAS, Roger e ANDRADE, Luciana Nogueira de Sousa e JANCAR, Sonia. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy. Nature reviews cancer. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/nrc.2017.15. Acesso em: 07 nov. 2024. , 2017
APA
Chammas, R., Andrade, L. N. de S., & Jancar, S. (2017). Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy. Nature reviews cancer. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1038/nrc.2017.15
NLM
Chammas R, Andrade LN de S, Jancar S. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy [Internet]. Nature reviews cancer. 2017 ; 17( 4):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/nrc.2017.15
Vancouver
Chammas R, Andrade LN de S, Jancar S. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy [Internet]. Nature reviews cancer. 2017 ; 17( 4):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/nrc.2017.15
Artigo de periodico
Induction of resident memory T cells enhances the efficacy of cancer (2017)
Nizard, Mevyn; Roussel, Hélène; Diniz, Mariana de Oliveira; Karaki, Soumaya; Tran, Thi; Voron, Thibault; Dransart, Estelle; Sandoval, Federico; Riquet, Marc; Rance, Bastien; Marcheteau, Elie; Fabre, Elizabeth; Mandavit, Marion; Terme, Magali; Blanc, Charlotte; Escudie, Jean-Baptiste; Gibault, Laure; Barthes, Françoise Le Pimpec; Granier, Clemence; Ferreira, Luís Carlos de Souza ; Badoual, Cecile; Johannes, Ludger; Tartour, Eric
Source: Nature Communications. Unidade: ICB
Subjects: MICROBIOLOGIA, LINFÓCITOS T, VACINAS, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NIZARD, Mevyn et al. Induction of resident memory T cells enhances the efficacy of cancer. Nature Communications, v. 8, n. 15221, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/ncomms15221. Acesso em: 07 nov. 2024.
APA
Nizard, M., Roussel, H., Diniz, M. de O., Karaki, S., Tran, T., Voron, T., et al. (2017). Induction of resident memory T cells enhances the efficacy of cancer. Nature Communications, 8( 15221), 1-11. doi:10.1038/ncomms15221
NLM
Nizard M, Roussel H, Diniz M de O, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie J-B, Gibault L, Barthes FLP, Granier C, Ferreira LC de S, Badoual C, Johannes L, Tartour E. Induction of resident memory T cells enhances the efficacy of cancer [Internet]. Nature Communications. 2017 ; 8( 15221): 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/ncomms15221
Vancouver
Nizard M, Roussel H, Diniz M de O, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie J-B, Gibault L, Barthes FLP, Granier C, Ferreira LC de S, Badoual C, Johannes L, Tartour E. Induction of resident memory T cells enhances the efficacy of cancer [Internet]. Nature Communications. 2017 ; 8( 15221): 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/ncomms15221
Artigo de periodico
MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma (2016)
Romitti, Miriam; Wajner, Simone Magagnin; Ceolin, Lucieli; Ferreira, Carla Vaz; Ribeiro, Rafaela Vanin Pinto; Rohenkohl, Helena Cecin; Weber, Shana de Souto; Lopez, Patrícia Luciana da Costa; Fuziwara, Cesar Seigi; Kimura, Edna Teruko ; Maia, Ana Luiza Silva
Source: Endocrine - Related Cancer. Unidade: ICB
Subjects: CARCINOMA, NEOPLASIAS, NEOPLASIAS DA TIREOIDE, HORMÔNIOS TIREOIDIANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMITTI, Miriam et al. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocrine - Related Cancer, v. 23, n. 3, p. 135-146, 2016Tradução . . Disponível em: http://lattes.cnpq.br/1377108494455149. Acesso em: 07 nov. 2024.
APA
Romitti, M., Wajner, S. M., Ceolin, L., Ferreira, C. V., Ribeiro, R. V. P., Rohenkohl, H. C., et al. (2016). MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocrine - Related Cancer, 23( 3), 135-146. doi:10.1530/ERC-15-0162
NLM
Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RVP, Rohenkohl HC, Weber S de S, Lopez PL da C, Fuziwara CS, Kimura ET, Maia ALS. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma [Internet]. Endocrine - Related Cancer. 2016 ; 23( 3): 135-146.[citado 2024 nov. 07 ] Available from: http://lattes.cnpq.br/1377108494455149
Vancouver
Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RVP, Rohenkohl HC, Weber S de S, Lopez PL da C, Fuziwara CS, Kimura ET, Maia ALS. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma [Internet]. Endocrine - Related Cancer. 2016 ; 23( 3): 135-146.[citado 2024 nov. 07 ] Available from: http://lattes.cnpq.br/1377108494455149
Artigo de periodico
Targeting prion protein interactions in cancer (2015)
Santos, Tiago Góss dos; Lopes, Marilene Hohmuth ; Martins, Vilma Regina
Source: Prion. Unidade: ICB
Subjects: HISTOLOGIA, NEOPLASIAS, PROTEINAS (INTERAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Tiago Góss dos e LOPES, Marilene Hohmuth e MARTINS, Vilma Regina. Targeting prion protein interactions in cancer. Prion, v. 9, n. 3, p. 165-173, 2015Tradução . . Disponível em: https://doi.org/10.1080/19336896.2015.1027855. Acesso em: 07 nov. 2024.
APA
Santos, T. G. dos, Lopes, M. H., & Martins, V. R. (2015). Targeting prion protein interactions in cancer. Prion, 9( 3), 165-173. doi:10.1080/19336896.2015.1027855
NLM
Santos TG dos, Lopes MH, Martins VR. Targeting prion protein interactions in cancer [Internet]. Prion. 2015 ; 9( 3): 165-173.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/19336896.2015.1027855
Vancouver
Santos TG dos, Lopes MH, Martins VR. Targeting prion protein interactions in cancer [Internet]. Prion. 2015 ; 9( 3): 165-173.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/19336896.2015.1027855
Artigo de periodico
Insights into regulation of the miR-17-92 cluster of miRNAs in cancer (2015)
Fuziwara, Cesar Seigi; Kimura, Edna Teruko
Source: Frontiers in Medicine. Unidade: ICB
Subjects: HISTOLOGIA, NEOPLASIAS, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZIWARA, Cesar Seigi e KIMURA, Edna Teruko. Insights into regulation of the miR-17-92 cluster of miRNAs in cancer. Frontiers in Medicine, v. 2, n. 64, p. 1-5, 2015Tradução . . Disponível em: https://doi.org/10.3389/fmed.2015.00064. Acesso em: 07 nov. 2024.
APA
Fuziwara, C. S., & Kimura, E. T. (2015). Insights into regulation of the miR-17-92 cluster of miRNAs in cancer. Frontiers in Medicine, 2( 64), 1-5. doi:10.3389/fmed.2015.00064
NLM
Fuziwara CS, Kimura ET. Insights into regulation of the miR-17-92 cluster of miRNAs in cancer [Internet]. Frontiers in Medicine. 2015 ; 2( 64): 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fmed.2015.00064
Vancouver
Fuziwara CS, Kimura ET. Insights into regulation of the miR-17-92 cluster of miRNAs in cancer [Internet]. Frontiers in Medicine. 2015 ; 2( 64): 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fmed.2015.00064
Artigo de periodico
Therapeutic applications of TRAIL receptor agonists in cancer and beyond (2015)
Amarante-Mendes, João Gustavo Pessini ; Griffith, Thomas S.
Source: Pharmacology & Therapeutics. Unidade: ICB
Subjects: CITOCINAS, NEOPLASIAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARANTE-MENDES, João Gustavo Pessini e GRIFFITH, Thomas S. Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & Therapeutics, v. 155, p. 117-131, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.pharmthera.2015.09.001. Acesso em: 07 nov. 2024.
APA
Amarante-Mendes, J. G. P., & Griffith, T. S. (2015). Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & Therapeutics, 155, 117-131. doi:10.1016/j.pharmthera.2015.09.001
NLM
Amarante-Mendes JGP, Griffith TS. Therapeutic applications of TRAIL receptor agonists in cancer and beyond [Internet]. Pharmacology & Therapeutics. 2015 ; 155 117-131.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.pharmthera.2015.09.001
Vancouver
Amarante-Mendes JGP, Griffith TS. Therapeutic applications of TRAIL receptor agonists in cancer and beyond [Internet]. Pharmacology & Therapeutics. 2015 ; 155 117-131.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.pharmthera.2015.09.001
Artigo de periodico
Cancer research in Brazil - stuck in second gear? (2015)
Lepique, Ana Paula ; Bonorino, C.
Source: Brazilian Journal of Medical and Biological Research. Unidade: ICB
Subjects: IMUNOLOGIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPIQUE, Ana Paula e BONORINO, C. Cancer research in Brazil - stuck in second gear?. Brazilian Journal of Medical and Biological Research, v. 48, n. 2, p. 108-110, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20144234. Acesso em: 07 nov. 2024.
APA
Lepique, A. P., & Bonorino, C. (2015). Cancer research in Brazil - stuck in second gear? Brazilian Journal of Medical and Biological Research, 48( 2), 108-110. doi:10.1590/1414-431X20144234
NLM
Lepique AP, Bonorino C. Cancer research in Brazil - stuck in second gear? [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 2): 108-110.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/1414-431X20144234
Vancouver
Lepique AP, Bonorino C. Cancer research in Brazil - stuck in second gear? [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 2): 108-110.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1590/1414-431X20144234
Artigo de periodico
NF-κBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients (2015)
Camargo, Rodolfo Gonzalez; Riccardi, Daniela Mendes dos Reis; Ribeiro, Henrique Quintas Teixeira; Carnevali Jr, Luiz Carlos; Matos-Neto, Emidio Marques de; Enjiu, Lucas; Neves, Rodrigo Xavier; Lima, Joanna Darck Carola Correia; Figuerêdo, Raquel Galvão; Alcântara, Paulo Sérgio Martins de; Maximiano, Linda Ferreira; Otoch, José Pinhata; Batista Jr, Miguel Luiz; Püschel, Gerhard; Seelaender, Marília Cerqueira Leite
Source: Nutrients. Unidades: HU, ICB
Subjects: NEOPLASIAS, PERDA DE PESO, INFLAMAÇÃO, TECIDO ADIPOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Rodolfo Gonzalez et al. NF-κBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients, v. 7, n. ju 2015, p. 4465-4479, 2015Tradução . . Disponível em: https://doi.org/10.3390/nu7064465. Acesso em: 07 nov. 2024.
APA
Camargo, R. G., Riccardi, D. M. dos R., Ribeiro, H. Q. T., Carnevali Jr, L. C., Matos-Neto, E. M. de, Enjiu, L., et al. (2015). NF-κBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients, 7( ju 2015), 4465-4479. doi:10.3390/nu7064465
NLM
Camargo RG, Riccardi DM dos R, Ribeiro HQT, Carnevali Jr LC, Matos-Neto EM de, Enjiu L, Neves RX, Lima JDCC, Figuerêdo RG, Alcântara PSM de, Maximiano LF, Otoch JP, Batista Jr ML, Püschel G, Seelaender MCL. NF-κBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients [Internet]. Nutrients. 2015 ; 7( ju 2015): 4465-4479.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/nu7064465
Vancouver
Camargo RG, Riccardi DM dos R, Ribeiro HQT, Carnevali Jr LC, Matos-Neto EM de, Enjiu L, Neves RX, Lima JDCC, Figuerêdo RG, Alcântara PSM de, Maximiano LF, Otoch JP, Batista Jr ML, Püschel G, Seelaender MCL. NF-κBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients [Internet]. Nutrients. 2015 ; 7( ju 2015): 4465-4479.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/nu7064465
Artigo de periodico
Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets (2015)
Romagnoli, Graziela Gorete; Zelante, Bruna Barbosa; Toniolo, Patricia Argenta; Migliori, Isabella Katz; Barbuto, José Alexandre Marzagão
Source: Frontiers in Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, CELULAS CULTIVADAS DE TUMOR, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMAGNOLI, Graziela Gorete et al. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, v. 5, p. 1-5, 2015Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2014.00692. Acesso em: 07 nov. 2024.
APA
Romagnoli, G. G., Zelante, B. B., Toniolo, P. A., Migliori, I. K., & Barbuto, J. A. M. (2015). Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, 5, 1-5. doi:10.3389/fimmu.2014.00692
NLM
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2014.00692
Vancouver
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2014.00692
Artigo de periodico
Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo (2014)
Benadiba, Marcel; Costa, Iguatinã de Melo; Santos, Rodrigo Luis da Silva Ribeiro dos; Serachi, Fernanda Oliveira; Silva, Denise de Oliveira ; Colquhoun, Alison
Source: Journal of Biological Inorganic Chemistry. Unidades: IQ, ICB
Subjects: GLIOMA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENADIBA, Marcel et al. Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo. Journal of Biological Inorganic Chemistry, v. 19, n. 6, p. 1025-1035, 2014Tradução . . Disponível em: https://doi.org/10.1007/s00775-014-1143-4. Acesso em: 07 nov. 2024.
APA
Benadiba, M., Costa, I. de M., Santos, R. L. da S. R. dos, Serachi, F. O., Silva, D. de O., & Colquhoun, A. (2014). Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo. Journal of Biological Inorganic Chemistry, 19( 6), 1025-1035. doi:10.1007/s00775-014-1143-4
NLM
Benadiba M, Costa I de M, Santos RL da SR dos, Serachi FO, Silva D de O, Colquhoun A. Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo [Internet]. Journal of Biological Inorganic Chemistry. 2014 ; 19( 6): 1025-1035.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00775-014-1143-4
Vancouver
Benadiba M, Costa I de M, Santos RL da SR dos, Serachi FO, Silva D de O, Colquhoun A. Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo [Internet]. Journal of Biological Inorganic Chemistry. 2014 ; 19( 6): 1025-1035.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00775-014-1143-4
Artigo de periodico
MicroRNA deregulation in anaplastic thyroid cancer biology (2014)
Fuziwara, Cesar Seigi; Kimura, Edna Teruko
Source: International Journal of Endocrinology. Unidade: ICB
Subjects: HISTOLOGIA, NEOPLASIAS DA TIREÓIDE, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZIWARA, Cesar Seigi e KIMURA, Edna Teruko. MicroRNA deregulation in anaplastic thyroid cancer biology. International Journal of Endocrinology, v. 2014, p. 1-8, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/743450. Acesso em: 07 nov. 2024.
APA
Fuziwara, C. S., & Kimura, E. T. (2014). MicroRNA deregulation in anaplastic thyroid cancer biology. International Journal of Endocrinology, 2014, 1-8. doi:10.1155/2014/743450
NLM
Fuziwara CS, Kimura ET. MicroRNA deregulation in anaplastic thyroid cancer biology [Internet]. International Journal of Endocrinology. 2014 ; 2014 1-8.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1155/2014/743450
Vancouver
Fuziwara CS, Kimura ET. MicroRNA deregulation in anaplastic thyroid cancer biology [Internet]. International Journal of Endocrinology. 2014 ; 2014 1-8.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1155/2014/743450
Artigo de periodico
The multiple facets of drug resistance: one history, different approaches (2014)
Niero, Evandro Luís; Sales, Bianca Rocha; Lauand, Camila; Cortez, Beatriz Araujo; Souza, Marcelo Medina de; Teixeira, Paula Rezende; Urabayashi, Marcel Shinti; Martens, Adam Arai; Neves, Jorge Henrique; Santelli, Glaucia Maria Machado
Source: Journal of Experimental and Clinical Cancer Research. Unidade: ICB
Subjects: HISTOLOGIA, NEOPLASIAS, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NIERO, Evandro Luís et al. The multiple facets of drug resistance: one history, different approaches. Journal of Experimental and Clinical Cancer Research, v. 33, n. 37, p. 1-17, 2014Tradução . . Disponível em: https://doi.org/10.1186/1756-9966-33-37. Acesso em: 07 nov. 2024.
APA
Niero, E. L., Sales, B. R., Lauand, C., Cortez, B. A., Souza, M. M. de, Teixeira, P. R., et al. (2014). The multiple facets of drug resistance: one history, different approaches. Journal of Experimental and Clinical Cancer Research, 33( 37), 1-17. doi:10.1186/1756-9966-33-37
NLM
Niero EL, Sales BR, Lauand C, Cortez BA, Souza MM de, Teixeira PR, Urabayashi MS, Martens AA, Neves JH, Santelli GMM. The multiple facets of drug resistance: one history, different approaches [Internet]. Journal of Experimental and Clinical Cancer Research. 2014 ; 33( 37): 1-17.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/1756-9966-33-37
Vancouver
Niero EL, Sales BR, Lauand C, Cortez BA, Souza MM de, Teixeira PR, Urabayashi MS, Martens AA, Neves JH, Santelli GMM. The multiple facets of drug resistance: one history, different approaches [Internet]. Journal of Experimental and Clinical Cancer Research. 2014 ; 33( 37): 1-17.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/1756-9966-33-37

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration